Sign in

NCT03959748Recruiting

DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL

Source: ClinicalTrials.gov · Last updated 22 May 2019 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The BNP-PL is a multicenter, observational study in which patients are prospectively followed in order to investigate clinical course and management of pulmonary hypertension in Poland. All patients diagnosed with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension confirmed in right heart catheterization, will be eligible to participate in the study.

Status (registry)
Recruiting
Study type
Observational
Enrollment
3000 (estimated)
First submitted
26 Mar 2019
Start date
1 Mar 2018
Primary completion date
28 Feb 2023
Lead sponsor
Polish Cardiology Association
NCT number
NCT03959748

What you commit to

  • Study type: Observational
  • Planned participants: 3000
  • From 1 Mar 2018 to the primary completion date, 28 Feb 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension diagnosed after 1st March 2018 (incident cases) who:
  • are aged \> 3 months at the time of enrollment
  • fulfill the following hemodinamic criteria: mean pulmonary arterial pressure (mPAP) of 25 mm Hg or more, mean pulmonary arterial wedge pressure (PAWP) or left ventricular end-diastolic pressure (PVEDP) of 15 mm Hg or less, pulmonary vascular resistance (PVR) of 3 Woods.
    • Patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension diagnosed before 1st March 2018 (prevalent cases) who:
  • are aged \> 3 months at the time of enrollment
  • fulfill the following hemodinamic criteria: mean pulmonary arterial pressure (mPAP) of 25 mm Hg or more, mean pulmonary arterial wedge pressure (PAWP) or left ventricular end-diastolic pressure (PVEDP) of 15 mm Hg or less, pulmonary vascular resistance (PVR) of 3 Woods

Age in the registry: 3 months to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Krakowski Szpital Specjalistyczny im. Jana Pawła II
Coordinator of this site? Confirm its status		KrakówPolandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.